1. Home
  2. BHRB vs TRAX Comparison

BHRB vs TRAX Comparison

Compare BHRB & TRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

N/A

Current Price

$72.05

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

TRAX

First Tracks Biotherapeutics Inc. Ordinary Shares

N/A

Current Price

$44.61

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHRB
TRAX
Founded
1852
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2023
2026

Fundamental Metrics

Financial Performance
Metric
BHRB
TRAX
Price
$72.05
$44.61
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
★ $80.00
$74.17
AVG Volume (30 Days)
132.3K
★ 1.1M
Earning Date
10-22-2026
11-12-2026
Dividend Yield
★ 3.12%
N/A
EPS Growth
★ 173.76
N/A
EPS
★ 2.16
N/A
Revenue
N/A
N/A
Revenue This Year
$26.77
N/A
Revenue Next Year
$11.76
N/A
P/E Ratio
$32.64
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$58.64
$15.69
52 Week High
$75.09
$49.91

Technical Indicators

Market Signals
Indicator
BHRB
TRAX
Relative Strength Index (RSI) 60.09 63.82
Support Level $70.30 $40.72
Resistance Level $73.83 $48.94
Average True Range (ATR) 1.57 3.07
MACD 0.25 0.91
Stochastic Oscillator 91.43 82.84

Price Performance

Historical Comparison
BHRB
TRAX

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

About TRAX First Tracks Biotherapeutics Inc. Ordinary Shares

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

Share on Social Networks: